• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促炎细胞因子(IL-6和IL-18)的表达会增加巴基斯坦人群患糖尿病肾病的风险。

Expression of pro-inflammatory cytokines (IL-6 & IL-18) exacerbate the risk of diabetic nephropathy in the Pakistani population.

作者信息

Maqsood Maha, Sharif Saima, Naz Shagufta, Farasat Tasnim, Manzoor Farkhanda, Cheema Maqsood, Saqib Muhammad

机构信息

Department of Zoology, Lahore College for Women University, Lahore, Pakistan.

DHQ Teaching Hospital Gujranwala, Civil Lines, Gujranwala, Pakistan.

出版信息

Mol Biol Rep. 2023 Apr;50(4):3249-3257. doi: 10.1007/s11033-023-08249-z. Epub 2023 Jan 28.

DOI:10.1007/s11033-023-08249-z
PMID:36708448
Abstract

BACKGROUND

Diabetic nephropathy (DN) is a micro-chronic diabetic consequence induced by metabolic and hemodynamic abnormalities. Free radicals react with other critical cellular components, causing progression of aberrant renal function.

OBJECTIVE

This case control study was aimed to determine the role of IL-6 and IL-18 in diabetic nephropathy in Pakistani population.

METHODS AND MATERIALS

The study's subjects (n = 180 from Lahore, Gujranwala, and Karachi) were divided into control, diabetes mellitus (DM) and diabetic nephropathy (DN) groups. The serum concentration of IL-6 & IL-18 were determined by enzyme-linked immunosorbent assay (ELISA). The expression analysis of IL-6 & IL-18 were performed by Real Time PCR.

RESULTS

The significant increase in serum levels of IL-6 were observed among the control, DM and DN groups (15.3 ± 24.1 pg/ml, 34.7 ± 24.0 pg/ml, 52.6 ± 33.2 pg/ml) whereas no significant difference was observed in serum levels of IL-18. The expression analysis of IL-6 was increased by more than forty three fold in DN group (n-fold = ~43.6) as compared to DM & control whereas the expression profile of IL-18 decreased in DN group (n-fold = ~0.89). In DN group the correlation analysis revealed direct association of GFR with serum IL-6 (r = 0.1114) & inverse relationship with serum IL-18 (r = - 0.097). In multiple regression analysis using GFR as the dependent variable, BMI and expression of IL-18 were determinants in DM subjects, but only uric acid in DN subjects.

CONCLUSION

The present study implicates that increased expression of IL-6 and decreased of IL-18 was associated with development of DN in Pakistani population.

摘要

背景

糖尿病肾病(DN)是一种由代谢和血流动力学异常引起的慢性糖尿病微血管并发症。自由基与其他关键细胞成分发生反应,导致肾功能异常进展。

目的

本病例对照研究旨在确定白细胞介素-6(IL-6)和白细胞介素-18(IL-18)在巴基斯坦人群糖尿病肾病中的作用。

方法和材料

研究对象(来自拉合尔、古杰兰瓦拉和卡拉奇的180例)分为对照组、糖尿病(DM)组和糖尿病肾病(DN)组。采用酶联免疫吸附测定(ELISA)法测定血清IL-6和IL-18浓度。通过实时荧光定量聚合酶链反应(Real Time PCR)进行IL-6和IL-18的表达分析。

结果

对照组、DM组和DN组血清IL-6水平显著升高(分别为15.3±24.1 pg/ml、34.7±24.0 pg/ml、52.6±33.2 pg/ml),而血清IL-18水平无显著差异。与DM组和对照组相比,DN组IL-6的表达分析增加了43倍以上(n倍=43.6),而DN组IL-18的表达谱降低(n倍=0.89)。在DN组中,相关性分析显示肾小球滤过率(GFR)与血清IL-6呈正相关(r=0.1114),与血清IL-18呈负相关(r=-0.097)。在以GFR为因变量的多元回归分析中,BMI和IL-18的表达是DM患者的决定因素,而在DN患者中只有尿酸是决定因素。

结论

本研究表明,IL-6表达增加和IL-18表达降低与巴基斯坦人群DN的发生有关。

相似文献

1
Expression of pro-inflammatory cytokines (IL-6 & IL-18) exacerbate the risk of diabetic nephropathy in the Pakistani population.促炎细胞因子(IL-6和IL-18)的表达会增加巴基斯坦人群患糖尿病肾病的风险。
Mol Biol Rep. 2023 Apr;50(4):3249-3257. doi: 10.1007/s11033-023-08249-z. Epub 2023 Jan 28.
2
Correlation between plasma long non-coding RNA MEG-3 and inflammatory cytokines in patients with diabetic nephropathy.糖尿病肾病患者血浆长链非编码RNA MEG-3与炎性细胞因子的相关性
Clin Nephrol. 2023 Aug;100(2):67-73. doi: 10.5414/CN110996.
3
Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression.关键炎症细胞因子的遗传变异通过影响基因表达加重了糖尿病肾病的风险。
Gene. 2018 Jun 30;661:51-59. doi: 10.1016/j.gene.2018.03.095. Epub 2018 Mar 29.
4
High levels of circulating interleukin-10 in diabetic nephropathy patients.糖尿病肾病患者循环白细胞介素-10水平升高。
Eur Cytokine Netw. 2005 Jun;16(2):117-22.
5
Elevated urinary IL-36α and IL-18 levels are associated with diabetic nephropathy in patients with type 2 diabetes mellitus.尿中 IL-36α 和 IL-18 水平升高与 2 型糖尿病患者的糖尿病肾病有关。
Minerva Endocrinol (Torino). 2021 Jun;46(2):226-232. doi: 10.23736/S2724-6507.20.03196-X.
6
Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population.探讨巴基斯坦 2 型糖尿病合并糖尿病肾病患者血管紧张素转化酶 2 基因(G8790A)多态性。
PLoS One. 2022 Feb 17;17(2):e0264038. doi: 10.1371/journal.pone.0264038. eCollection 2022.
7
Interplay between long non-coding RNA MALAT1 and pyroptosis in diabetic nephropathy patients.长链非编码 RNA MALAT1 与糖尿病肾病患者 pyroptosis 的相互作用。
Gene. 2023 Jan 30;851:146978. doi: 10.1016/j.gene.2022.146978. Epub 2022 Oct 18.
8
Helicobacter pylori infection associated with type 2 diabetic nephropathy in patients with dyspeptic symptoms.幽门螺杆菌感染与消化不良症状的 2 型糖尿病肾病患者相关。
Diabetes Res Clin Pract. 2015 Dec;110(3):328-34. doi: 10.1016/j.diabres.2015.09.008. Epub 2015 Sep 25.
9
Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.血清微小 RNA152-3p 在伴有进行性肾病的 2 型糖尿病中的过表达。
Egypt J Immunol. 2020 Jun;27(2):81-92.
10
Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.网膜素-1和白细胞介素-6在2型糖尿病肾病患者中的作用。
Diabetes Metab Syndr. 2018 Jan-Mar;12(1):23-26. doi: 10.1016/j.dsx.2017.08.005. Epub 2017 Aug 24.

引用本文的文献

1
Association of the IL-6R rs2228145 polymorphism with diabetic nephropathy: A case-control study.白细胞介素-6受体基因rs2228145多态性与糖尿病肾病的关联:一项病例对照研究。
J Diabetes Investig. 2025 Aug;16(8):1463-1472. doi: 10.1111/jdi.70073. Epub 2025 May 29.
2
Potential therapeutic effects of crocin.藏红花素的潜在治疗作用。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7395-7420. doi: 10.1007/s00210-024-03131-6. Epub 2024 May 17.
3
Determination of Glyoxalase-1 levels and Identification of Genetic Variants in Gene in Patients of Diabetic Nephropathy.

本文引用的文献

1
Increased Expression of Circulating Stress Markers, Inflammatory Cytokines and Decreased Antioxidant Level in Diabetic Nephropathy.糖尿病肾病患者循环应激标志物、炎症细胞因子表达增加,抗氧化水平降低。
Medicina (Kaunas). 2022 Nov 7;58(11):1604. doi: 10.3390/medicina58111604.
2
Impaired Glomerular Filtration Rate in Type 2 Diabetes Mellitus Subjects: A Nationwide Cross-Sectional Study in Thailand.2 型糖尿病患者肾小球滤过率受损:泰国全国性横断面研究。
J Diabetes Res. 2020 Aug 12;2020:6353949. doi: 10.1155/2020/6353949. eCollection 2020.
3
Study on Risk Factors of Diabetic Nephropathy in Obese Patients with Type 2 Diabetes Mellitus.
糖尿病肾病患者中乙二醛酶-1水平的测定及该基因遗传变异的鉴定
Pak J Med Sci. 2024 Mar-Apr;40(4):652-656. doi: 10.12669/pjms.40.4.8258.
肥胖2型糖尿病患者糖尿病肾病危险因素的研究
Int J Gen Med. 2020 Jul 6;13:351-360. doi: 10.2147/IJGM.S255858. eCollection 2020.
4
Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6.血清白细胞介素-32 水平在 2 型糖尿病患者中的变化及其与肿瘤坏死因子-α和白细胞介素-6 的关系。
Cytokine. 2020 Jan;125:154832. doi: 10.1016/j.cyto.2019.154832. Epub 2019 Aug 31.
5
Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: Logistic regression and classification tree model analysis.上海社区 2 型糖尿病患者糖尿病肾病并发症的危险因素:Logistic 回归和分类树模型分析。
Int J Health Plann Manage. 2019 Jul;34(3):1013-1024. doi: 10.1002/hpm.2871. Epub 2019 Jul 31.
6
Interleukin-18 and diabetic nephropathy: A review.白细胞介素-18 与糖尿病肾病:综述。
J Cell Physiol. 2019 May;234(5):5674-5682. doi: 10.1002/jcp.27427. Epub 2018 Nov 11.
7
Oxidative stress induces renal failure: A review of possible molecular pathways.氧化应激导致肾衰竭:可能的分子途径综述。
J Cell Biochem. 2018 Apr;119(4):2990-2998. doi: 10.1002/jcb.26450. Epub 2018 Jan 2.
8
Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study.白细胞介素-18基因多态性作为代谢综合征炎症指标的初步研究
World J Diabetes. 2017 Jun 15;8(6):304-310. doi: 10.4239/wjd.v8.i6.304.
9
Inflammatory cytokines in diabetic nephropathy.糖尿病肾病中的炎性细胞因子。
J Diabetes Res. 2015;2015:948417. doi: 10.1155/2015/948417. Epub 2015 Feb 15.
10
Targeting inflammation in diabetes: Newer therapeutic options.针对糖尿病炎症:新的治疗选择。
World J Diabetes. 2014 Oct 15;5(5):697-710. doi: 10.4239/wjd.v5.i5.697.